scholarly journals Associations between functional tricuspid regurgitation and long-term outcomes for patients with pulmonary hypertension

2020 ◽  
Vol 36 (7) ◽  
pp. 1261-1269
Author(s):  
Jun Mukai ◽  
Hidekazu Tanaka ◽  
Hiroyuki Sano ◽  
Shun Yokota ◽  
Makiko Suto ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Tricuspid Regurgitation ◽  
Long Term Outcomes ◽  
Functional Tricuspid Regurgitation

ASSOCIATION OF TRICUSPID REGURGITATION WITH LONG-TERM OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION

2019 ◽  
Vol 73 (9) ◽  
pp. 1915
Author(s):  
Jun Mukai ◽  
Hidekazu Tanaka ◽  
Hiroyuki Sano ◽  
Kentaro Yamashita ◽  
Yusuke Tanaka ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Tricuspid Regurgitation ◽  
Long Term Outcomes

Surgical indication for functional tricuspid regurgitation at initial operation: judging from long term outcomes

2016 ◽  
Vol 64 (9) ◽  
pp. 509-516 ◽  
Author(s):  
Alberto Pozzoli ◽  
Lapenna Elisabetta ◽  
Luca Vicentini ◽  
Ottavio Alfieri ◽  
Michele De Bonis
Keyword(s):  
Tricuspid Regurgitation ◽  
Surgical Indication ◽  
Initial Operation ◽  
Long Term Outcomes ◽  
Functional Tricuspid Regurgitation

scholarly journals Long-Term Outcomes of Suture vs. Ring Tricuspid Annuloplasty for Functional Tricuspid Regurgitation

2017 ◽  
Vol 81 (10) ◽  
pp. 1432-1438 ◽  
Author(s):  
Hiroki Hata ◽  
Tomoyuki Fujita ◽  
Sayaka Miura ◽  
Yusuke Shimahara ◽  
Yuta Kume ◽  
...  
Keyword(s):  
Tricuspid Regurgitation ◽  
Long Term Outcomes ◽  
Tricuspid Annuloplasty ◽  
Functional Tricuspid Regurgitation

scholarly journals Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol

2017 ◽  
Vol 8 (1) ◽  
pp. 204589321774805 ◽  
Author(s):  
Barbara L. LeVarge ◽  
Anica C. Law ◽  
Blanche Murphy
Keyword(s):  
Pulmonary Hypertension ◽  
Pulmonary Arterial Hypertension ◽  
Adverse Events ◽  
Arterial Hypertension ◽  
Long Term Outcomes ◽  
Pulmonary Arterial

Infection, thrombosis, and catheter dislodgment are well-recognized potential complications of chronic intravenous prostanoid therapy for pulmonary arterial hypertension. As long-term outcomes of pulmonary hypertension patients improve, novel adverse events are likely to arise. We describe the sudden development of unexplained hypotension and lightheadedness in a patient receiving intravenous epoprostenol for several years, ultimately determined to be due to an unusual catheter complication, not previously described in this population.

Sign in / Sign up

Export Citation Format

Share Document